May 9, 2011 - Initial findings from the SAVI Collaborative Research Project (SCRP), on SAVI radiation therapy for breast cancer, were presented at the recent annual meeting of the American Brachytherapy Society (ABS).

May 9, 2011 – IBA announced today at the European Society for Therapeutic Radiology and Oncology conference that it has signed an agreement with Axios Oncology for the worldwide distribution of the company’s radiation therapy software solutions, RadCheck and BrachyCheck. With the addition of this software suite to its product portfolio, IBA offers enhanced solutions for radiation therapy to address quality assurance and patient safety needs.

May 6, 2011 – Naviscan has entered into a distribution agreement with Tecnologie Avanzate s.r.l. to market and service Naviscan’s high-resolution, organ-specific PET scanner in Italy. The agreement represents the introduction of PEM (Positron Emission Mammography), the scanner’s breast application, as a new tool available to Italian women in their fight against breast cancer.

May 6, 2011 – Nucletron will feature five new innovations at the ESTRO Anniversary Congress, May 8-11 in London, all designed to meet the growing interest and need to more effectively treat a wide variety of cancers. In addition Nucletron will be celebrating its long collaboration with ESTRO on its 30th anniversary.

May 6, 2011 – Two articles in the June issue of The Journal of Nuclear Medicine make a case for maintaining current U.S. Nuclear Regulatory Commission (NRC) regulations on the release of patients who undergo radioactive iodine treatments for thyroid cancer, known as I-131 therapy. Currently, the NRC recommends outpatient treatment for patients receiving radioactive iodine after total or near-total thyroidectomy.

May 6, 2011 – The U.S. Food and Drug Administration has released its list of pre-market approval (PMA) decisions for new or enhanced medical devices from March 2011.

May 6, 2011 – Functionality in the echo ultrasound market drives satisfaction as providers push the bounds of what the technology can do to treat an increasing number of patients at risk for cardiovascular disease. Vendors have responded to these demands with new systems and new technology over the last couple of years.

Subscribe Now